1. Home
  2. NYXH vs OXSQ Comparison

NYXH vs OXSQ Comparison

Compare NYXH & OXSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NYXH
  • OXSQ
  • Stock Information
  • Founded
  • NYXH 2009
  • OXSQ 2003
  • Country
  • NYXH Belgium
  • OXSQ United States
  • Employees
  • NYXH N/A
  • OXSQ N/A
  • Industry
  • NYXH Medical/Dental Instruments
  • OXSQ Blank Checks
  • Sector
  • NYXH Health Care
  • OXSQ Finance
  • Exchange
  • NYXH Nasdaq
  • OXSQ Nasdaq
  • Market Cap
  • NYXH 222.3M
  • OXSQ 190.1M
  • IPO Year
  • NYXH 2021
  • OXSQ N/A
  • Fundamental
  • Price
  • NYXH $5.78
  • OXSQ $2.48
  • Analyst Decision
  • NYXH Strong Buy
  • OXSQ
  • Analyst Count
  • NYXH 4
  • OXSQ 0
  • Target Price
  • NYXH $14.50
  • OXSQ N/A
  • AVG Volume (30 Days)
  • NYXH 117.0K
  • OXSQ 446.5K
  • Earning Date
  • NYXH 05-14-2025
  • OXSQ 04-25-2025
  • Dividend Yield
  • NYXH N/A
  • OXSQ 17.00%
  • EPS Growth
  • NYXH N/A
  • OXSQ N/A
  • EPS
  • NYXH N/A
  • OXSQ N/A
  • Revenue
  • NYXH $4,680,609.00
  • OXSQ $42,166,831.00
  • Revenue This Year
  • NYXH $323.07
  • OXSQ $8.73
  • Revenue Next Year
  • NYXH $204.30
  • OXSQ N/A
  • P/E Ratio
  • NYXH N/A
  • OXSQ N/A
  • Revenue Growth
  • NYXH 3.98
  • OXSQ N/A
  • 52 Week Low
  • NYXH $5.55
  • OXSQ $2.28
  • 52 Week High
  • NYXH $12.21
  • OXSQ $3.28
  • Technical
  • Relative Strength Index (RSI)
  • NYXH 34.87
  • OXSQ 45.76
  • Support Level
  • NYXH $6.03
  • OXSQ $2.44
  • Resistance Level
  • NYXH $6.66
  • OXSQ $2.48
  • Average True Range (ATR)
  • NYXH 0.33
  • OXSQ 0.05
  • MACD
  • NYXH 0.11
  • OXSQ 0.00
  • Stochastic Oscillator
  • NYXH 15.38
  • OXSQ 31.25

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

About OXSQ Oxford Square Capital Corp.

Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing, and Diversified Insurance.

Share on Social Networks: